Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jodi M Carter

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Pathology|February 10, 2018
Giant Cell Tumor of Bone in Patients 55 Years and Older: A Study of 34 PatientsCory J Broehm, Carrie Y Inwards, Alyaa Al-Ibraheemi, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 31, 2021
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumorFlorian Puls, Jodi M Carter, Nischalan Pillay, et al.
Cancer Research|December 5, 2022
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast CancerLixuan Wei, Huanyao Gao, Jia Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2020
Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast BiopsyMark E Sherman, Robert A Vierkant, Suneetha Kaggal, et al.
Scientific Reports|January 12, 2023
PDJ amplicon in triple negative breast cancerAlexander S Roesler, Smriti Malasi, Lori Koslosky, et al.
HGG Advances|January 20, 2022
An activating germline <i>IDH1</i> variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoidPatrick R Blackburn, Jodi M Carter, Devin Oglesbee, et al.
NPJ Breast Cancer|November 8, 2022
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancerCaner Mercan, Maschenka Balkenhol, Roberto Salgado, et al.
Breast Cancer Research and Treatment|November 2, 2017
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changesDaniel Kerekes, Daniel W Visscher, Tanya L Hoskin, et al.
JAMA Surgery|December 13, 2023
Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy EraMark E Sherman, Robert A Vierkant, Stacey J Winham, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Pathology|February 10, 2018
Giant Cell Tumor of Bone in Patients 55 Years and Older: A Study of 34 PatientsCory J Broehm, Carrie Y Inwards, Alyaa Al-Ibraheemi, et al.
Cancer Research|May 21, 2021
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling NetworksIshwar N Kohale, Danielle M Burgenske, Ann C Mladek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 31, 2021
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumorFlorian Puls, Jodi M Carter, Nischalan Pillay, et al.
Cancer Research|December 5, 2022
Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast CancerLixuan Wei, Huanyao Gao, Jia Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2020
Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast BiopsyMark E Sherman, Robert A Vierkant, Suneetha Kaggal, et al.
Scientific Reports|January 12, 2023
PDJ amplicon in triple negative breast cancerAlexander S Roesler, Smriti Malasi, Lori Koslosky, et al.
HGG Advances|January 20, 2022
An activating germline <i>IDH1</i> variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoidPatrick R Blackburn, Jodi M Carter, Devin Oglesbee, et al.
NPJ Breast Cancer|November 8, 2022
Deep learning for fully-automated nuclear pleomorphism scoring in breast cancerCaner Mercan, Maschenka Balkenhol, Roberto Salgado, et al.
Breast Cancer Research and Treatment|November 2, 2017
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changesDaniel Kerekes, Daniel W Visscher, Tanya L Hoskin, et al.
JAMA Surgery|December 13, 2023
Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy EraMark E Sherman, Robert A Vierkant, Stacey J Winham, et al.
Pageof 12